SKIN SQUAMOUS CELL CARCINOMA RECURRENT

SKIN SQUAMOUS CELL CARCINOMA RECURRENT was reported 114 times

SKIN SQUAMOUS CELL CARCINOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lymphocyte Growth Factor [EPC] 3 0.0024
1 Blood Viscosity Reducer [EPC] 5 0.0012
2 Adenosine Receptor Agonist [EPC] 4 0.0005
3 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0002
4 Epidermal Growth Factor Receptor Antagonist [EPC] 8 0.0002
5 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 2 0.0002
6 Human Immunoglobulin G [EPC] 3 0.0001
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 14 0.0001
8 Antimetabolite Immunosuppressant [EPC] 3 0.0001
9 Provitamin D2 Compound [EPC] 3 0.0001
10 Bile Acid [EPC] 2 0.0001
11 Interleukin-23 Antagonist [EPC] 8 0.0001
12 Janus Kinase Inhibitor [EPC] 12 0.0001
13 Peroxisome Proliferator Receptor alpha Agonist [EPC] 4 0.0001
14 Integrin Receptor Antagonist [EPC] 5 0.0001
15 Kinase Inhibitor [EPC] 27 0.0000
16 Insulin [EPC] 2 0.0000
17 Sulfonylurea [EPC] 5 0.0000
18 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1 0.0000
19 Aromatic Amino Acid [EPC] 2 0.0000
20 Azole Antifungal [EPC] 5 0.0000
21 Corticosteroid [EPC] 37 0.0000
22 Potassium Channel Blocker [EPC] 2 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 8 0.0000
24 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
25 Nitrate Vasodilator [EPC] 2 0.0000
26 Purine Antimetabolite [EPC] 2 0.0000
27 Ester Local Anesthetic [EPC] 1 0.0000
28 Interleukin-12 Antagonist [EPC] 2 0.0000
29 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 5 0.0000
31 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
32 BCL-2 Inhibitor [EPC] 1 0.0000
33 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
34 Thiazide Diuretic [EPC] 3 0.0000
35 Androgen Receptor Inhibitor [EPC] 1 0.0000
36 Calcium [EPC] 2 0.0000
37 Non-Standardized Chemical Allergen [EPC] 1 0.0000
38 Retinoid [EPC] 3 0.0000
39 Amide Local Anesthetic [EPC] 1 0.0000
40 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
41 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
42 Antiarrhythmic [EPC] 1 0.0000
43 Endothelin Receptor Antagonist [EPC] 2 0.0000
44 Aminosalicylate [EPC] 1 0.0000
45 5-alpha Reductase Inhibitor [EPC] 1 0.0000
46 Vitamin C [EPC] 4 0.0000
47 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
48 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
49 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
50 alpha-Adrenergic Blocker [EPC] 1 0.0000
51 Platelet Aggregation Inhibitor [EPC] 4 0.0000
52 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
53 Proton Pump Inhibitor [EPC] 4 0.0000
54 Loop Diuretic [EPC] 3 0.0000
55 Estrogen [EPC] 1 0.0000
56 Alkylating Drug [EPC] 1 0.0000
57 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
58 Thalidomide Analog [EPC] 2 0.0000
59 Vitamin D [EPC] 1 0.0000
60 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
61 Vitamin B12 [EPC] 1 0.0000
62 GLP-1 Receptor Agonist [EPC] 1 0.0000
63 Insulin Analog [EPC] 1 0.0000
64 Atypical Antipsychotic [EPC] 1 0.0000
65 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
66 Benzodiazepine [EPC] 1 0.0000